Effective delivery of large genes to the retina by dual AAV vectors
Open accessThe DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.
Abstract
Retinal gene therapy with adeno‐associated viral (AAV) vectors is safe and effective in humans. However, AAV's limited cargo capacity prevents its application to therapies of inherited retinal diseases due to mutations of genes over 5 kb, like Stargardt's disease (STGD) and Usher syndrome type IB (USH1B). Previous methods based on ‘forced’ packaging of large genes into AAV capsids may not be easily translated to the clinic due to the generation of genomes of heterogeneous size which raise safety concerns. Taking advantage of AAV's ability to concatemerize, we generated dual AAV vectors which reconstitute a large gene by either splicing (trans‐splicing), homologous recombination (overlapping), or a combination of the two (hybrid). We found that dual trans‐splicing and hybrid vectors transduce efficiently mouse and pig photoreceptors to levels that, albeit lower than those achieved with a single AAV, resulted in significant improvement of the retinal phenotype of mouse models of STGD and USH1B. Thus, dual AAV trans‐splicing or hybrid vectors are an attractive strategy for gene therapy of retinal diseases that require delivery of large genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Even though vector reconstitution in the retina has been detected for clinically relevant large transgenes, such as ABCA4 or MYO7A, due to lack of proper controls (e.g., using oversized monocistronic vectors) and accurate protein quantification methods, determining parameters for clinical approaches has been lacking (Dyka et al., 2014; Trapani et al., 2014, 2015).”
From Evaluating Efficiencies of Dual AAV Approaches for Retinal Targeting (2017) · cites this paper as Trapani et al., 2014
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it is worth remembering that the multiplicity of infection is about 10 4 - 10 5 vector particles at the level of the RPE, depending on the disease state at the time of treatment (Trapani et al., 2014; Ramachandran et al., 2017).”
From Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy (2025) · cites this paper as Trapani et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“advances in dual and triple AAV vectors with enhanced cargo capacity now allow for the delivery of larger genes [242], including anti-VEGF and complement regulatory molecules”
From Bruch’s Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration (2023) · cites this paper as [242]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The hybrid dual AAV strategy was initially proposed by Gosh and colleagues in 2008 [54] and found to significantly improve transgene reassembly in a variety of studies thereafter [29,49].”
From Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders (2022) · cites this paper as [29]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In their study, Trapani et al. demonstrated that in vitro transduction with vectors with oversized genomes did not result in efficient transgene expression. 46”
From Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids (2016) · cites this paper as [46]
Experimental — accuracy not yet measured
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Modern Applied Statistics with S
Venables, W. N., & Ripley, B. D. (2002) · Statistics and Computing · doi:10.1007/978-0-387-21706-2 · Cited by 24,305
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
A monomeric red fluorescent protein
Campbell, R. E., Tour, O., Palmer, A. E., Steinbach, P. A., Baird, G. S., Zacharias, D. A., & Tsien, R. Y. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082243699 · Cited by 2,365
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145 · cited 2×
“…gene therapy is effective in animal models and in patients with inherited blinding conditions (Jacobson et al , 2006; Bainbridge et al , 2008; Maguire et al , 2008, 2009; Cideciyan et al , 2009; Simonelli et al , 2010), its application to diseases affecting the retina and requiring a…”
Self-citationEffect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924 · cited 1×
“While AAV-mediated gene therapy is effective in animal models and in patients with inherited blinding conditions (Jacobson et al , 2006; Bainbridge et al , 2008; Maguire et al , 2008, 2009; Cideciyan et al , 2009; Simonelli et al , 2010), its application to diseases affecting the retina and…”
Allikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-236 · Cited by 1,435
Effect of genome size on AAV vector packaging
Wu, Z., Yang, H., & Colosi, P. (2010) · Molecular Therapy · doi:10.1038/mt.2009.255 · Cited by 1,029
Weng, J., Mata, N. L., Azarian, S. M., Tzekov, R. T., Birch, D. G., & Travis, G. H. (1999) · Cell · doi:10.1016/s0092-8674(00)80602-9 · Cited by 881 · cited 5×
“ABCA4 and MYO7A expression was normalized to Filamin A or Dysferlin for the in vitro and in vivo experiments, respectively.”
InfluentialMaguire, A. M., High, K. A., Auricchio, A., Wright, J. F., Pierce, E. A., Testa, F., Mingozzi, F., Bennicelli, J. L., Ying, G.-S., Rossi, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61836-5 · Cited by 865 · cited 2×
“…gene therapy is effective in animal models and in patients with inherited blinding conditions (Jacobson et al , 2006; Bainbridge et al , 2008; Maguire et al , 2008, 2009; Cideciyan et al , 2009; Simonelli et al , 2010), its application to diseases affecting the retina and requiring a…”
Self-citationSimonelli, F., Maguire, A. M., Testa, F., Pierce, E. A., Mingozzi, F., Bennicelli, J. L., Rossi, S., Marshall, K., Banfi, S., Surace, E. M., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.277 · Cited by 553
Self-citationDuan, D., Sharma, P., Yang, J., Yue, Y., Dudus, L., Zhang, Y., Fisher, K. J., & Engelhardt, J. F. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8568-8577.1998 · Cited by 522
Parish, C. A., Hashimoto, M., Nakanishi, K., Dillon, J., & Sparrow, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14609 · Cited by 474 · cited 4×
“We additionally attempted at measuring A2E, the major component of lipofuscin granules, by HPLC (Parish et al , 1998; Ben-Shabat et al , 2002; Alloc-ca et al , 2008), however these measurements were inconsistent, even between affected and normal retinas (data not shown), thus we were not able to…”
InfluentialHasson, T., Heintzelman, M. B., Santos-Sacchi, J., Corey, D. P., & Mooseker, M. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9815 · Cited by 427
Grieger, J. C., & Samulski, R. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9933-9944.2005 · Cited by 419
Flotte, T. R., Afione, S. A., Solow, R., Drumm, M. L., Markakis, D., Guggino, W. B., Zeitlin, P. L., & Carter, B. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53762-5 · Cited by 342
Testa, F., Maguire, A. M., Rossi, S., Pierce, E. A., Melillo, P., Marshall, K., Banfi, S., Surace, E. M., Sun, J., Acerra, C., et al. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.11.048 · Cited by 330
Self-citationPrevalence of mutations causing retinitis pigmentosa and other inherited retinopathies
Sohocki, M. M., Daiger, S. P., Bowne, S. J., Rodriquez, J. A., Northrup, H., Heckenlively, J. R., Birch, D. G., Mintz-Hittner, H., Ruiz, R. S., Lewis, R. A., et al. (2001) · Human Mutation · doi:10.1002/1098-1004(2001)17:1<42::aid-humu5>3.0.co;2-k · Cited by 329
Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy
Yan, Z., Zhang, Y., Duan, D., & Engelhardt, J. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6716 · Cited by 305
The 220-kDa Rim Protein of Retinal Rod Outer Segments Is a Member of the ABC Transporter Superfamily
Illing, M., Molday, L. L., & Molday, R. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.10303 · Cited by 304
Auricchio, A., Hildinger, M., O'Connor, E., Gao, G.-P., & Wilson, J. M. (2001) · Human Gene Therapy · doi:10.1089/104303401450988 · Cited by 297
Self-citationMyosin VIIa Participates in Opsin Transport through The Photoreceptor Cilium
Liu, X., Udovichenko, I. P., Brown, S. D. M., Steel, K. P., & Williams, D. S. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06267.1999 · Cited by 293
Allocca, M., Doria, M., Petrillo, M., Colella, P., Garcia-Hoyos, M., Gibbs, D., Kim, S. R., Maguire, A., Rex, T. S., Di Vicino, U., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34316 · Cited by 292 · cited 18×
“…al , 2008; Monahan et al , 2010; Grose et al , 2012; Lopes et al , 2013), including the retina of the Abca4 (cid:1) / (cid:1) and shaker 1 ( sh1 ) mouse models of STGD and USH1B (Allocca et al , 2008; Lopes et al , 2013), the mechanism underlying oversize AAV-mediated transduction remains elusive.”
InfluentialSelf-citationDuan, D., Yue, Y., & Engelhardt, J. F. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0456 · Cited by 262 · cited 2×
“…undergo intermolecular concatemerization (Duan et al , 1998) is exploited to transfer large genes in vivo by splitting a large gene expression cassette into halves ( < 5 kb in size), each contained in one of two separate (dual) AAV vectors (Yan et al , 2000; Duan et al , 2001; Ghosh et al , 2008).”
DNA repair in neurons: So if they don’t divide what's to repair?
Fishel, M. L., Vasko, M. R., & Kelley, M. R. (2007) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2006.06.007 · Cited by 256
Stargardt's ABCR is localized to the disc membrane of retinal rod outer segments
Sun, H., & Nathans, J. (1997) · Nature Genetics · doi:10.1038/ng0997-15 · Cited by 251 · cited 1×
“…severe PR degeneration (Wu et al , 2010a), the absence of the ABCA4-encoded all-trans retinal transporter in PR outer segments (Illing et al , 1997; Sun & Nathans, 1997) causes an accumulation of lipo-fuscin in PR as well as in RPE, as result of PR phagocytosis by RPE (Weng et al , 1999; Mata et…”
Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors
Allocca, M., Mussolino, C., Garcia-Hoyos, M., Sanges, D., Iodice, C., Petrillo, M., Vandenberghe, L. H., Wilson, J. M., Marigo, V., Surace, E. M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01327-07 · Cited by 246
Self-citationMata, N. L., Tzekov, R. T., Liu, X., Weng, J., Birch, D. G., & Travis, G. H. (2001) · PubMed · Cited by 242
Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey
Vandenberghe, L. H., Bell, P., Maguire, A. M., Cearley, C. N., Xiao, R., Calcedo, R., Wang, L., Castle, M. J., Maguire, A. C., Grant, R., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002103 · Cited by 242
Characterization of Genome Integrity for Oversized Recombinant AAV Vector
Dong, B., Nakai, H., & Xiao, W. (2010) · Molecular Therapy · doi:10.1038/mt.2009.258 · Cited by 230 · cited 4×
“Following infection, re-assembly of these truncated genomes in the target cell nucleus has been proposed as a mechanism for oversize AAV vector transduction (Dong et al , 2010a; Hirsch et al , 2010, 2013; Lai et al , 2010; Wu et al , 2010b).”
InfluentialAn Update on the Genetics of Usher Syndrome
Millán, J. M., Aller, E., Jaijo, T., Blanco-Kelly, F., Gimenez-Pardo, A., & Ayuso, C. (2011) · Journal of Ophthalmology · doi:10.1155/2011/417217 · Cited by 225
Jacobson, S. G., Acland, G. M., Aguirre, G. D., Aleman, T. S., Schwartz, S. B., Cideciyan, A. V., Zeiss, C. J., Komaromy, A. M., Kaushal, S., Roman, A. J., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.005 · Cited by 224
Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors
Lai, Y., Yue, Y., Liu, M., Ghosh, A., Engelhardt, J. F., Chamberlain, J. S., & Duan, D. (2005) · Nature Biotechnology · doi:10.1038/nbt1153 · Cited by 224 · cited 1×
“Trans-splicing has been successfully used to express large genes in muscle and retina (Reich et al , 2003; Lai et al , 2005).”
Biosynthetic Studies of A2E, a Major Fluorophore of Retinal Pigment Epithelial Lipofuscin
Ben-Shabat, S., Parish, C. A., Vollmer, H. R., Itagaki, Y., Fishkin, N., Nakanishi, K., & Sparrow, J. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108981200 · Cited by 214 · cited 2×
“We additionally attempted at measuring A2E, the major component of lipofuscin granules, by HPLC (Parish et al , 1998; Ben-Shabat et al , 2002; Alloc-ca et al , 2008), however these measurements were inconsistent, even between affected and normal retinas (data not shown), thus we were not able to…”
Efficacy of tribromoethanol anesthesia in mice.
Papaioannou, V. E., & Fox, J. G. (1993) · PubMed · Cited by 201
Vision 1 Year after Gene Therapy for Leber's Congenital Amaurosis
Cideciyan, A. V., Hauswirth, W. W., Aleman, T. S., Kaushal, S., Schwartz, S. B., Boye, S. L., Windsor, E. A. M., Conlon, T. J., Sumaroka, A., Roman, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0903652 · Cited by 199
Liu, X., Vansant, G., Udovichenko, I. P., Wolfrum, U., & Williams, D. S. (1997) · Cell Motility and the Cytoskeleton · doi:10.1002/(sici)1097-0169(1997)37:3<240::aid-cm6>3.0.co;2-a · Cited by 191
Radu, R. A., Yuan, Q., Hu, J., Peng, J. H., Lloyd, M., Nusinowitz, S., Bok, D., & Travis, G. H. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1470 · Cited by 188 · cited 2×
“In addition, Abca4 (cid:1) / (cid:1) mice also show delayed recovery from light desensitization (Weng et al , 1999; Maiti et al , 2006; Allocca et al , 2008; Radu et al , 2008; Han et al , 2012).”
Gao, G., Qu, G., Burnham, M. S., Huang, J., Chirmule, N., Joshi, B., Yu, Q.-C., Marsh, J. A., Conceicao, C. M., & Wilson, J. M. (2000) · Human Gene Therapy · doi:10.1089/104303400750001390 · Cited by 174
Mutant myosin VIIa causes defective melanosome distribution in the RPE of shaker-1 mice
Liu, X., Ondek, B., & Williams, D. S. (1998) · Nature Genetics · doi:10.1038/470 · Cited by 168 · cited 11×
“Although administration of oversize AAV vectors achieves thera-peutically-relevant levels of transgene expression in rodent and canine models of human inherited diseases (Allocca et al , 2008; Monahan et al , 2010; Grose et al , 2012; Lopes et al , 2013), including the retina of the Abca4 (cid:1) / (cid:1) and shaker…”
InfluentialRadu, R. A., Mata, N. L., Bagla, A., & Travis, G. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308302101 · Cited by 167
Evidence for the Failure of Adeno-associated Virus Serotype 5 to Package a Viral Genome ≥8.2 kb
Lai, Y., Yue, Y., & Duan, D. (2010) · Molecular Therapy · doi:10.1038/mt.2009.256 · Cited by 166
Congenital hypothyroidism caused by a mutation in the Na+/l− symporter
Fujiwara, H., Tatsumi, K.-I., Miki, K., Harada, T., Miyai, K., Takai, S.-I., & Amino, N. (1997) · Nature Genetics · doi:10.1038/ng0697-124 · Cited by 164
Ghosh, A., Yue, Y., Lai, Y., & Duan, D. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300322 · Cited by 161 · cited 3×
“A third dual AAV strategy (hybrid) is based on adding a highly recombinogenic region from an exogenous gene [i.e. alkaline phosphatase, AP (Ghosh et al, 2008, 2011)] to the trans-splicing vectors.”
BackgroundDNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice
Han, Z., Conley, S. M., Makkia, R. S., Cooper, M. J., & Naash, M. I. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64833 · Cited by 150
Natkunarajah, M., Trittibach, P., McIntosh, J., Duran, Y., Barker, S. E., Smith, A. J., Nathwani, A. C., & Ali, R. R. (2008) · Gene Therapy · doi:10.1038/sj.gt.3303074 · Cited by 138
Novel adeno-associated viral vectors for retinal gene therapy.
Vandenberghe, L. H., & Auricchio, A. (2012) · Gene Therapy · doi:10.1038/gt.2011.151 · Cited by 131
Self-citation(1997) · Nature Genetics · doi:10.1038/ng0997-122b · Cited by 130
Monahan, P. E., Lothrop, C. D., Sun, J., Hirsch, M. L., Kafri, T., Kantor, B., Sarkar, R., Tillson, D. M., Elia, J. R., & Samulski, R. J. (2010) · Molecular Therapy · doi:10.1038/mt.2010.170 · Cited by 125
Zhang, Y., Chirmule, N., Gao, G.-P., & Wilson, J. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8003-8010.2000 · Cited by 119
Retinal gene therapy with a large MYO7A cDNA using adeno-associated virus
Lopes, V. S., Boye, S. E., Louie, C. M., Boye, S., Dyka, F., Chiodo, V, Fofo, H., Hauswirth, W. W., & Williams, D. S. (2013) · Gene Therapy · doi:10.1038/gt.2013.3 · Cited by 112
Analysis of the VMD2 Promoter and Implication of E-box Binding Factors in Its Regulation
Esumi, N., Oshima, Y., Li, Y., Campochiaro, P. A., & Zack, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309881200 · Cited by 110
Wu, J., Zhao, W., Zhong, L., Han, Z., Li, B., Ma, W., Weigel-Kelley, K. A., Warrington, K. H., & Srivastava, A. (2007) · Human Gene Therapy · doi:10.1089/hum.2006.088 · Cited by 108
Yan, Z., Zak, R., Zhang, Y., & Engelhardt, J. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.364-379.2005 · Cited by 107 · cited 1×
“This is consistent with the knowledge that the mechanism of large gene reconstitution mediated by dual AAV TS and hybrid AK approaches may be via ITR-mediated head-to-tail rejoining (Duan et al , 1998; Yan et al , 2005; Ghosh et al , 2008) rather than homologous recombination.”
Small Molecule RPE65 Antagonists Limit the Visual Cycle and Prevent Lipofuscin Formation
Maiti, P., Kong, J., Kim, S. R., Sparrow, J. R., Allikmets, R., & Rando, R. R. (2006) · Biochemistry · doi:10.1021/bi0518545 · Cited by 106
AAV-mediated photoreceptor transduction of the pig cone-enriched retina
Mussolino, C., della Corte, M., Rossi, S., Viola, F., Di Vicino, U., Marrocco, E., Neglia, S., Doria, M., Testa, F., Giovannoni, R., et al. (2011) · Gene Therapy · doi:10.1038/gt.2011.3 · Cited by 102
Self-citationHermonat, P. L., Quirk, J. G., Bishop, B. M., & Han, L. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00311-6 · Cited by 98 · cited 1×
“However, a major limitation of AAV is its cargo capacity, which is thought to be limited to around 5 kb, the size of the parental viral genome (Hermonat et al , 1997; Dong et al , 2010a; Lai et al , 2010; Wu et al , 2010b; Wang et al , 2012).”
Reich, S. J., Auricchio, A., Hildinger, M., Glover, E., Maguire, A. M., Wilson, J. M., & Bennett, J. (2003) · Human Gene Therapy · doi:10.1089/10430340360464697 · Cited by 96 · cited 2×
“Trans-splicing has been successfully used to express large genes in muscle and retina (Reich et al , 2003; Lai et al , 2005).”
Self-citationGhosh, A., Yue, Y., & Duan, D. (2011) · Human Gene Therapy · doi:10.1089/hum.2010.122 · Cited by 95
Little Vector, Big Gene Transduction: Fragmented Genome Reassembly of Adeno-associated Virus
Hirsch, M. L., Agbandje-McKenna, M., & Jude Samulski, R. (2010) · Molecular Therapy · doi:10.1038/mt.2009.280 · Cited by 85
Ma, L., Kaufman, Y., Zhang, J., & Washington, I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178657 · Cited by 83 · cited 1×
“As a consequence, both the number of lipofuscin granules in the RPE and the thickness of RPE cells are greater in Abca4 (cid:1) / (cid:1) mice than in control mice (Allocca et al , 2008; Radu et al , 2008; Ma et al , 2011; Conley et al , 2012; Han et al , 2012).”
Defective lipid transport and biosynthesis in recessive and dominant Stargardt macular degeneration
Molday, R. S., & Zhang, K. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.002 · Cited by 82
Ocular gene therapy: current progress and future prospects
Colella, P., Cotugno, G., & Auricchio, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.11.003 · Cited by 78
Self-citationPhotoreceptor Cell Degeneration in Abcr –/– Mice
Wu, L., Nagasaki, T., & Sparrow, J. R. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-1399-9_61 · Cited by 77
Grose, W. E., Clark, K. R., Griffin, D., Malik, V., Shontz, K. M., Montgomery, C. L., Lewis, S., Brown, R. H., Janssen, P. M. L., Mendell, J. R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039233 · Cited by 76 · cited 1×
“…levels of transgene expression in rodent and canine models of human inherited diseases (Allocca et al , 2008; Monahan et al , 2010; Grose et al , 2012; Lopes et al , 2013), including the retina of the Abca4 (cid:1) / (cid:1) and shaker 1 ( sh1 ) mouse models of STGD and USH1B…”
Ghosh, A., Yue, Y., & Duan, D. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.835 · Cited by 69 · cited 2×
“We additionally generated AAV OZ and dual AAV vectors including the reporter EGFP sequence with the exception of the dual AAV OV approach since its efficiency relies on transgene-specific overlaps for reconstitution (Ghosh et al , 2006) and therefore can not be extrapolated from one gene to another.”
Intraocular Delivery of Recombinant Virus
Liang, F.-Q., Anand, V., Maguire, A. M., & Bennett, J. (2003) · Vision Research Protocols · doi:10.1385/1-59259-085-3:125 · Cited by 68
Oversized AAV Transductifon Is Mediated via a DNA-PKcs-independent, Rad51C-dependent Repair Pathway
Hirsch, M. L., Li, C., Bellon, I., Yin, C., Chavala, S., Pryadkina, M., Richard, I., & Samulski, R. J. (2013) · Molecular Therapy · doi:10.1038/mt.2013.184 · Cited by 62
Gargiulo, A., Bonetti, C., Montefusco, S., Neglia, S., Di Vicino, U., Marrocco, E., Corte, M. D., Domenici, L., Auricchio, A., & Surace, E. M. (2009) · Molecular Therapy · doi:10.1038/mt.2009.112 · Cited by 61
Self-citationDoria, M., Ferrara, A., & Auricchio, A. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.155 · Cited by 56
Self-citationConley, S. M., Cai, X., Makkia, R., Wu, Y., Sparrow, J. R., & Naash, M. I. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.007 · Cited by 54
Function of MYO7A in the Human RPE and the Validity of Shaker1 Mice as a Model for Usher Syndrome 1B
Gibbs, D., Diemer, T., Khanobdee, K., Hu, J., Bok, D., & Williams, D. S. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4032 · Cited by 48
High throughput production, screening and analysis of adeno-associated viral vectors
Drittanti, L., Rivet, C., Manceau, P., Danos, O., & Vega, M. T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301191 · Cited by 48
Efficacy of Codelivery of Dual AAV2/5 Vectors in the Murine Retina and Hippocampus
Palfi, A., Chadderton, N., McKee, A. G., Blanco Fernandez, A., Humphries, P., Kenna, P. F., & Farrar, G. J. (2012) · Human Gene Therapy · doi:10.1089/hum.2011.142 · Cited by 42 · cited 3×
“…dual AAV TS vectors carrying the lacZ reporter gene (Reich et al , 2003) or with two single vectors encoding different fluorescent reporter proteins (Palfi et al , 2012), our study represents the first comprehensive comparison in the retina of the dual AAV strategies reported so far, as well as the…”
InfluentialSelf-citationYan, Z., Lei-Butters, D. C. M., Zhang, Y., Zak, R., & Engelhardt, J. F. (2007) · Human Gene Therapy · doi:10.1089/hum.2006.128 · Cited by 41 · cited 5×
“1 (Auricchio et al , 2001) plasmids that contain the inverted terminal repeats (ITRs) of AAV serotype 2 (supplementary Table S1).”
InfluentialWang, Y., Ling, C., Song, L., Wang, L., Aslanidi, G. V., Tan, M., Ling, C., & Srivastava, A. (2012) · Human Gene Therapy Methods · doi:10.1089/hgtb.2012.090 · Cited by 37
Mouse Models for Usher Syndrome 1b
Lillo, C., Kitamoto, J., Liu, X., Quint, E., Steel, K. P., & Williams, D. S. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0067-4_18 · Cited by 27
AAV Recombineering with Single Strand Oligonucleotides
Hirsch, M. L., Storici, F., Li, C., Choi, V. W., & Samulski, R. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007705 · Cited by 26
Mass spectrometry provides accurate and sensitive quantitation of A2E
Gutierrez, D. B., Blakeley, L. R., Goletz, P. W., Schey, K. L., Hanneken, A. M., Koutalos, Y., Crouch, R. K., & Ablonczy, Z. (2010) · Photochemical & Photobiological Sciences · doi:10.1039/c0pp00230e · Cited by 23
Establishment of an AAV Reverse Infection-Based Array
Dong, X., Tian, W., Wang, G., Dong, Z., Shen, W., Zheng, G., Wu, X., Xue, J., Wang, Y., & Chen, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013479 · Cited by 20
Fighting Blindness with Adeno-Associated Virus Serotype 8
Auricchio, A. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.2521 · Cited by 10
Self-citation
Cited by
Emerging issues in AAV-mediated in vivo gene therapy
Colella, P., Ronzitti, G., & Mingozzi, F. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.11.007 · Cited by 881
Self-citationEngineering adeno-associated viruses for clinical gene therapy
Kotterman, M. A., & Schaffer, D. V. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3742 · Cited by 761
Current clinical applications of in vivo gene therapy with AAVs
Mendell, J. R., Al-Zaidy, S. A., Rodino-Klapac, L. R., Goodspeed, K., Gray, S. J., Kay, C. N., Boye, S. L., Boye, S. E., George, L. A., Salabarria, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.007 · Cited by 743
“Efforts are currently underway by multiple groups to develop dual AAV vector platforms that will promote delivery of large genes to PRs.108,109 Beyond monogenic disease, AAV is also being used to vectorize antivascular endothelial growth factor (VEGF) reagents to the retina via SRI to serve as a one-time treatment for…”
BackgroundAAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
Costa Verdera, H., Kuranda, K., & Mingozzi, F. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.12.010 · Cited by 641
AAV vectors: The Rubik’s cube of human gene therapy
Pupo, A., Fernández, A., Low, S. H., François, A., Suárez-Amarán, L., & Samulski, R. J. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.09.015 · Cited by 360
Metadata
- Authors
- Trapani, I., Colella, P., Sommella, A., Iodice, C., Cesi, G., de Simone, S., Marrocco, E., Rossi, S., Giunti, M., Palfi, A., Farrar, G. J., Polishchuk, R., & Auricchio, A.
- Affiliations
- Telethon Institute Of Genetics And Medicine (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- University of Bologna (IT)
- Trinity College Dublin (IE)
- Federico II University Hospital (IT)
- Corresponding author
- Auricchio, Alberto
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2013-12-16
- Volume
- 6
- Issue
- 2
- Pages
- 194-211
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC3927955
- OpenAlex
- W2137826201
- Cited by
- 269
- References
- 82
- Citations by year
- 2026: 18 · 2025: 30 · 2024: 17 · 2023: 24 · 2022: 18 · 2021: 24 · 2020: 31 · 2019: 22 · 2018: 22 · 2017: 23 · 2016: 9 · 2015: 17 · 2014: 13 · 2013: 1
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/3.0/ (tdm)
- creativecommons.org/licenses/by/3.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Funders
- European Research Council/ERC (282085)
- European Community's Seventh Framework Programme (242013)
- NIH (R24 RY019861‐01A)
- Italian Telethon Foundation (TGM11MT1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- adeno-associated virus, retinal gene therapy, trans-splicing, homologous recombination, hybrid vectors, Stargardt disease, photoreceptors, inherited retinal disease
- MeSH terms
- Stargardt Disease, Myosin VIIa, Dependovirus, Animals, Disease Models, Animal, Genetic Vectors, Humans, Injections, Lipofuscin, Macular Degeneration, Mice, Inbred C57BL, Myosins, Phenotype, Retina, Rhodopsin, Transduction, Genetic, Gene Transfer Techniques, ATP-Binding Cassette Transporters, Trans-Splicing, Photoreceptor Cells, Vertebrate, Melanosomes, Sus scrofa, Mice, Usher Syndromes, Retinal Pigment Epithelium, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.